Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.

NCT01616381 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT01616381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01616381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.
Lead sponsor
Helse Stavanger HF
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2013
Completion date
December 31, 2019
Enrollment
75 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, pulmonary hypertension